Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)

NCT06574789 is registered in ClinicalTrials.gov with Murdoch Childrens Research Institute as lead sponsor.

NCT NCT06574789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06574789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)
Lead sponsor
Murdoch Childrens Research Institute
Phase
Phase 2
Overall status
Recruiting
Start date
October 29, 2024
Completion date
December 31, 2028
Enrollment
232 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus viraemia